Dr. Amin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
500 Upper Chesapeake Dr
Kaufman Cancer Center
Bel Air, MD 21014Phone+1 443-643-1199Fax+1 443-643-1198
Education & Training
- University of ColoradoResidency, Radiation Oncology, 2008 - 2012
- Drexel University College of Medicine/Hahnemann University HospitalInternship, Internal Medicine, 2007 - 2008
- Perelman School of Medicine at the University of PennsylvaniaClass of 2007
- University of PennsylvaniaBS, BAS, Wharton - Management; Engineering - Bioengineering, Summa Cum Laude, 1999 - 2003
- University of PennsylvaniaBS, Economics, Summa Cum Laude
- Wharton School of BusinessBS, Bioengineering
Certifications & Licensure
- CA State Medical License 2014 - Present
- MD State Medical License 2014 - 2026
- NJ State Medical License 2020 - 2025
- MI State Medical License 2012 - 2016
- CO State Medical License 2008 - 2014
- PA State Medical License 2007 - 2008
- American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- First Place for Poster Session I University of Maryland School of Medicine 40th Annual Medical Student Research Day, 2017
- Seattle Prostate Brachytherapy Fellowship 2011
- Fellows Recognition Program NCCN, 2011
- Join now to see all
Clinical Trials
- Radiation Therapy, Chemotherapy, and Soy Isoflavones in Treating Patients With Stage IIIA-IIIB Non-Small Cell Lung Cancer Start of enrollment: 2014 Aug 01
Publications & Presentations
PubMed
- 39 citationsAdvances in proton therapy in lung cancer.Melissa A.L. Vyfhuis, N. Onyeuku, Tejan Diwanji, Sina Mossahebi, Neha P. Amin
Therapeutic Advances in Respiratory Disease. 2018-01-01 - 23 citationsNivolumab plus rucaparib for metastatic castration-resistant prostate cancer: results from the phase 2 CheckMate 9KD trial.Karim Fizazi, Margitta Retz, Daniel P Petrylak, Jeffrey C Goh, Jose Perez-Gracia
Journal for Immunotherapy of Cancer. 2022-08-01 - 3 citationsCardiac Monitoring for Thoracic Radiation Therapy: Survey of Practice Patterns in the United States.Neha P. Amin, N. Desai, Samuel M. Kim, Manuj Agarwal, Nivee Amin
American Journal of Clinical Oncology. 2020-01-17
Journal Articles
- Multi-institutional Report on Radiation and NivolumabAmin NP, Zainib M, Parker S, Agarwal M, Mattes M., Adv Radiat Oncol., 1/1/2018
- Multi-institutional report on toxicities from combined Radiation and NivolumabS. Parker, M. Zainib, M. Mattes, N. Amin, J Clin Oncol, 1/1/2018
- Serum microRNA guiding personalized radiation therapy in non-small cell lung cancerAmin NP, Mohindra P, Jabbour SK, J Thorac Dis, 1/1/2018
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Safety and Effectiveness Outcomes of Lung Stereotactic Body Radiation Therapy (SBRT) in a Very Elderly Population: A Single Institution ExperienceA. Chhabra, L. Trombetta, A. Turkaj, T. Diwanji, B. Zhang, N. Lamichhane, P. Mohindra, S. Badiyan, S. Feigenberg, C. Simone, N. Amin, IJROBP, Proceedings of 59th Annual ASTRO meeting, 1/1/2017
- Multicenter Report on Toxicities of Concurrent Nivolumab and Radiation TherapyN. Amin, A. Chhabra, P. Mohindra, C. Simone, Z. Vujaskovic, IJROBP, Proceedings of 59th Annual ASTRO meeting, 1/1/2017
- Technique to improve R50 conformality for lung SBRT on Helical TomotherapyH. Beydoun, M. Dominello, P. Paximadis, N. Amin, S. Miller, A. Nalichowski., IJROBP, Proceedings of 59th Annual ASTRO meeting, 1/1/2017
- Join now to see all
Lectures
- Alertness Management & Fatigue Mitigation Training1/6./2015
- Long Term Control Outcomes Utilizing Cesium-131 Prostate Brachytherapy: Single Institution ExperienceSan Francisco, CA - 1/7./2018
- Advances in Radiation Techniques for Breast Cancer1/16/2018
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: